The recent disruptions in global chains have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes nations to considerable vulnerabilities, including delivery delays, price fluctuations, and even trade concerns. Shifting towards domestic procurement of Ivermectin offers a multitude